Different Units By MoH Code
Revision Date : 11/01/2013
NovoSeven RT 250KIU MoH 5541 :
Form |
Powder and solvent for solution for injection |
Packaging |
Pre-filled Syringes + Vials (Type I glass) |
Package Size |
1+1 |
Strength |
5mg (250KIU) |
Public Price |
308590539,56 L.L. |
Stratum |
E2 |
NSSF |
✔ |
Quarantine |
✘ |
Reg. Number |
218017/09 |
Submission date |
01/01/2009 |
Registration Year |
2009 |
●
Country:
|
Italy
|
●
Package Size:
|
1+1x5.2ml
|
●
Public Price:
|
5395.61 EUR
|
( 99,171,581.58 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
5395,61 EUR
|
( 99,160,369.75 LBP )
|
●
Exfactory Price:
|
3269.25 EUR
|
●
Pricing Date:
|
17/12/2019
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Qatar
|
●
Package Size:
|
1 powder vial + 1 Solvent pre-filled syringe + vial adapter
|
●
Public Price:
|
19816 QAR
|
( 82,247,496.96 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
19816 QAR
|
( 82,247,496.96 LBP )
|
●
Pharmacy Price:
|
16277.33865628 QAR
|
( 67560070.73321 LBP )
|
●
Pricing Date:
|
28/01/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Oman
|
●
Package Size:
|
1+1
|
●
Public Price:
|
2086.42 OMR
|
( 81,997,349.21 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
2086,42 OMR
|
( 81,980,843.00 LBP )
|
●
Pricing Date:
|
19/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Kuweit
|
●
Package Size:
|
1+1
|
●
Public Price:
|
1596.98 KWD
|
( 79,162,426.36 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1596,98 KWD
|
( 79,113,847.68 LBP )
|
●
Pharmacy Price:
|
1349.17 KWD
|
( 66878464.8336 LBP )
|
●
Pricing Date:
|
07/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Abu Dhabi
|
●
Package Size:
|
1+1
|
●
Public Price:
|
18517 AED
|
( 76,122,646.32 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
●
Pharmacy Price:
|
15773.8 AED
|
( 64845460.848 LBP )
|
●
Pricing Date:
|
27/01/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
UAE
|
●
Package Size:
|
1 Vial (Powder) + 1 Solvent Vial (2.1ml)
|
●
Public Price:
|
18517 AED
|
( 76,122,646.32 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
●
Pharmacy Price:
|
15773.78 AED
|
( 64845378.6288 LBP )
|
●
Pricing Date:
|
21/08/2019
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Switzerland
|
●
Package Size:
|
1+1
|
●
Public Price:
|
4370.8 CHF
|
( 74,566,940.70 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
4370,8 CHF
|
( 74,553,292.50 LBP )
|
●
Exfactory Price:
|
4224.2 CHF
|
●
Pricing Date:
|
04/04/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Finland
|
●
Package Size:
|
1+1
|
●
Public Price:
|
3888.15 EUR
|
( 71,464,391.41 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
3888,15 EUR
|
( 71,461,634.40 LBP )
|
●
Reference:
|
Kela
|
●
Pricing Date:
|
22/04/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Bahrain
|
●
Package Size:
|
1+1
|
●
Public Price:
|
1761.26 BHD
|
( 70,663,107.37 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1761,26 BHD
|
( 70,652,675.97 LBP )
|
●
Reference:
|
nhra
|
●
Pricing Date:
|
09/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Denmark
|
●
Package Size:
|
1+1
|
●
Public Price:
|
26563.3 DKK
|
( 65,371,484.40 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
26563,3 DKK
|
( 65,370,746.11 LBP )
|
●
Pharmacy Price:
|
19744.6 DKK
|
( 48590868.262 LBP )
|
●
Reference:
|
Danish Medicine Agency
|
●
Pricing Date:
|
19/05/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Iceland
|
●
Package Size:
|
1+1
|
●
Public Price:
|
532896 ISK
|
( 59,076,850.56 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
532896 ISK
|
( 59,076,850.56 LBP )
|
●
Pharmacy Price:
|
423362 ISK
|
( 46933911.32 LBP )
|
●
Reference:
|
Icelandic Medicines Agency
|
●
Pricing Date:
|
01/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Czech Republic
|
●
Package Size:
|
1+1x5.2ml
|
●
Public Price:
|
85264.46 CZK
|
( 58,897,278.39 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
85264,46 CZK
|
( 58,896,960.64 LBP )
|
●
Reference:
|
SUKL
|
●
Pricing Date:
|
28/02/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Spain
|
●
Package Size:
|
1 vial + 1xdisolvente
|
●
Public Price:
|
3062.98 EUR
|
( 56,297,725.55 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
3062,98 EUR
|
( 56,279,713.10 LBP )
|
●
Reference:
|
Agencia Española de Medicamentos y Productos Sanitarios
|
●
Pricing Date:
|
06/05/2021
|
●
Type:
|
Medicine Non Marketed
|
●
Country:
|
France
|
●
Package Size:
|
1+1
|
●
Public Price:
|
3040 EUR
|
( 55,875,352.00 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
3040 EUR
|
( 55,875,352.00 LBP )
|
●
Reference:
|
ansm
|
●
Pricing Date:
|
15/05/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
KSA
|
●
Package Size:
|
3mg
|
●
Public Price:
|
13202.15 SAR
|
( 53,209,681.32 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
13202,15 SAR
|
( 53,209,076.76 LBP )
|
●
Reference:
|
sfda
|
●
Pricing Date:
|
16/01/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
UK
|
●
Package Size:
|
1+1
|
●
Public Price:
|
2626 GBP
|
( 52,915,922.02 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
2626 GBP
|
( 52,915,922.02 LBP )
|
●
Reference:
|
DMD
|
●
Pricing Date:
|
08/03/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Norway
|
●
Package Size:
|
1
|
●
Public Price:
|
30097 NOK
|
( 52,075,936.19 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
30097 NOK
|
( 52,075,936.19 LBP )
|
●
Pharmacy Price:
|
23577.07 NOK
|
( 40794696.9089 LBP )
|
●
Reference:
|
Norwegian Medicine Agency
|
●
Pricing Date:
|
01/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Sweden
|
●
Package Size:
|
1+1
|
●
Public Price:
|
28482.76 SEK
|
( 51,272,101.10 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
28482,76 SEK
|
( 51,270,733.02 LBP )
|
●
Pharmacy Price:
|
27878.93 SEK
|
( 50185140.6823 LBP )
|
●
Pricing Date:
|
23/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Belgium
|
●
Package Size:
|
1+1x5.2ml
|
●
Public Price:
|
2662 EUR
|
( 48,927,693.10 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
2662 EUR
|
( 48,927,693.10 LBP )
|
●
Medica Comments:
|
Withdrawn on november 2018
|
●
Reference:
|
cbip
|
●
Pricing Date:
|
02/12/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Turkey
|
●
Package Size:
|
1
|
●
Public Price:
|
12895.82 TRY
|
( 24,768,872.52 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
12895,82 TRY
|
( 24,767,297.55 LBP )
|
●
Pricing Date:
|
28/10/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Lebanon
|
●
Form:
|
Powder and solvent for solution for injection
|
●
Package Size:
|
1+1
|
●
Public Price:
|
5033515 LBP
|
( 5,033,515.00 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
5033515 LBP
|
( 5,033,515.00 LBP )
|
●
Pricing Date:
|
10/01/2024
|
●
Country:
|
The Netherlands
|
●
Package Size:
|
1
|
●
Reference:
|
Zorginstituut Nederland
|
●
Pricing Date:
|
15/06/2019
|
●
Type:
|
Medicine Non Marketed
|
●
Country:
|
Greece
|
●
Package Size:
|
1+1
|
●
Reference:
|
National Organization for Medicines
|
●
Pricing Date:
|
25/03/2019
|
●
Type:
|
Medicine Non Marketed
|
●
Country:
|
New Zealand
|
●
Package Size:
|
1 inj
|
●
Exfactory Price:
|
5891.5 NZD
|
●
Reference:
|
New Zealand Pharmaceutical Management Agency
|
●
Pricing Date:
|
01/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Portugal
|
●
Package Size:
|
1+1
|
●
Reference:
|
Autoridade Nacional do Medicamento e Produtos de Saúde
|
●
Pricing Date:
|
22/04/2019
|
Acquired haemophilia :
●
Cost/Unit:
|
5395,61 EUR
|
( 99,160,369.75 LBP )
|
● Cost/Day:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
●
Cost/Month:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
5395,61 EUR
|
( 99,160,369.75 LBP )
|
● Cost/Day:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
●
Cost/Month:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
5395,61 EUR
|
( 99,160,369.75 LBP )
|
● Cost/Day:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
●
Cost/Month:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
5395,61 EUR
|
( 99,160,369.75 LBP )
|
● Cost/Day:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
●
Cost/Month:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
5395,61 EUR
|
( 99,160,369.75 LBP )
|
● Cost/Day:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
●
Cost/Month:
|
10791,22 EUR
|
( 198,339,119.55 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
19816 QAR
|
( 82,247,496.96 LBP )
|
● Cost/Day:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
●
Cost/Month:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
19816 QAR
|
( 82,247,496.96 LBP )
|
● Cost/Day:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
●
Cost/Month:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
19816 QAR
|
( 82,247,496.96 LBP )
|
● Cost/Day:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
●
Cost/Month:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
19816 QAR
|
( 82,247,496.96 LBP )
|
● Cost/Day:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
●
Cost/Month:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
19816 QAR
|
( 82,247,496.96 LBP )
|
● Cost/Day:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
●
Cost/Month:
|
39632 QAR
|
( 164,494,993.92 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
2086,42 OMR
|
( 81,980,843.00 LBP )
|
● Cost/Day:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
●
Cost/Month:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
2086,42 OMR
|
( 81,980,843.00 LBP )
|
● Cost/Day:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
●
Cost/Month:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
2086,42 OMR
|
( 81,980,843.00 LBP )
|
● Cost/Day:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
●
Cost/Month:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
2086,42 OMR
|
( 81,980,843.00 LBP )
|
● Cost/Day:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
●
Cost/Month:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
2086,42 OMR
|
( 81,980,843.00 LBP )
|
● Cost/Day:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
●
Cost/Month:
|
4172,84 OMR
|
( 163,961,686.00 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1596,98 KWD
|
( 79,113,847.68 LBP )
|
● Cost/Day:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
●
Cost/Month:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1596,98 KWD
|
( 79,113,847.68 LBP )
|
● Cost/Day:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
●
Cost/Month:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1596,98 KWD
|
( 79,113,847.68 LBP )
|
● Cost/Day:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
●
Cost/Month:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1596,98 KWD
|
( 79,113,847.68 LBP )
|
● Cost/Day:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
●
Cost/Month:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1596,98 KWD
|
( 79,113,847.68 LBP )
|
● Cost/Day:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
●
Cost/Month:
|
3193,96 KWD
|
( 158,277,265.44 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
18517 AED
|
( 76,122,646.32 LBP )
|
● Cost/Day:
|
37034 AED
|
( 152,245,292.64 LBP )
|
●
Cost/Month:
|
37034 AED
|
( 152,245,292.64 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
4370,8 CHF
|
( 74,553,292.50 LBP )
|
● Cost/Day:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
●
Cost/Month:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
4370,8 CHF
|
( 74,553,292.50 LBP )
|
● Cost/Day:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
●
Cost/Month:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
4370,8 CHF
|
( 74,553,292.50 LBP )
|
● Cost/Day:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
●
Cost/Month:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
4370,8 CHF
|
( 74,553,292.50 LBP )
|
● Cost/Day:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
●
Cost/Month:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
4370,8 CHF
|
( 74,553,292.50 LBP )
|
● Cost/Day:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
●
Cost/Month:
|
8741,6 CHF
|
( 149,123,645.25 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
3888,15 EUR
|
( 71,461,634.40 LBP )
|
● Cost/Day:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
●
Cost/Month:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
3888,15 EUR
|
( 71,461,634.40 LBP )
|
● Cost/Day:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
●
Cost/Month:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
3888,15 EUR
|
( 71,461,634.40 LBP )
|
● Cost/Day:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
●
Cost/Month:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
3888,15 EUR
|
( 71,461,634.40 LBP )
|
● Cost/Day:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
●
Cost/Month:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
3888,15 EUR
|
( 71,461,634.40 LBP )
|
● Cost/Day:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
●
Cost/Month:
|
7776,3 EUR
|
( 142,923,268.80 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1761,26 BHD
|
( 70,652,675.97 LBP )
|
● Cost/Day:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
●
Cost/Month:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1761,26 BHD
|
( 70,652,675.97 LBP )
|
● Cost/Day:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
●
Cost/Month:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1761,26 BHD
|
( 70,652,675.97 LBP )
|
● Cost/Day:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
●
Cost/Month:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1761,26 BHD
|
( 70,652,675.97 LBP )
|
● Cost/Day:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
●
Cost/Month:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1761,26 BHD
|
( 70,652,675.97 LBP )
|
● Cost/Day:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
●
Cost/Month:
|
3522,52 BHD
|
( 141,305,351.94 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
26563,3 DKK
|
( 65,370,746.11 LBP )
|
● Cost/Day:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
●
Cost/Month:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
26563,3 DKK
|
( 65,370,746.11 LBP )
|
● Cost/Day:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
●
Cost/Month:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
26563,3 DKK
|
( 65,370,746.11 LBP )
|
● Cost/Day:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
●
Cost/Month:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
26563,3 DKK
|
( 65,370,746.11 LBP )
|
● Cost/Day:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
●
Cost/Month:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
26563,3 DKK
|
( 65,370,746.11 LBP )
|
● Cost/Day:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
●
Cost/Month:
|
53126,6 DKK
|
( 130,741,492.22 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
532896 ISK
|
( 59,076,850.56 LBP )
|
● Cost/Day:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
●
Cost/Month:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
532896 ISK
|
( 59,076,850.56 LBP )
|
● Cost/Day:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
●
Cost/Month:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
532896 ISK
|
( 59,076,850.56 LBP )
|
● Cost/Day:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
●
Cost/Month:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
532896 ISK
|
( 59,076,850.56 LBP )
|
● Cost/Day:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
●
Cost/Month:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
532896 ISK
|
( 59,076,850.56 LBP )
|
● Cost/Day:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
●
Cost/Month:
|
1065792 ISK
|
( 118,153,701.12 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
85264,46 CZK
|
( 58,896,960.64 LBP )
|
● Cost/Day:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
●
Cost/Month:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
85264,46 CZK
|
( 58,896,960.64 LBP )
|
● Cost/Day:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
●
Cost/Month:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
85264,46 CZK
|
( 58,896,960.64 LBP )
|
● Cost/Day:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
●
Cost/Month:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
85264,46 CZK
|
( 58,896,960.64 LBP )
|
● Cost/Day:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
●
Cost/Month:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
85264,46 CZK
|
( 58,896,960.64 LBP )
|
● Cost/Day:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
●
Cost/Month:
|
170528,92 CZK
|
( 117,793,921.28 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
3062,98 EUR
|
( 56,279,713.10 LBP )
|
● Cost/Day:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
●
Cost/Month:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
3062,98 EUR
|
( 56,279,713.10 LBP )
|
● Cost/Day:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
●
Cost/Month:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
3062,98 EUR
|
( 56,279,713.10 LBP )
|
● Cost/Day:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
●
Cost/Month:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
3062,98 EUR
|
( 56,279,713.10 LBP )
|
● Cost/Day:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
●
Cost/Month:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
3062,98 EUR
|
( 56,279,713.10 LBP )
|
● Cost/Day:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
●
Cost/Month:
|
6125,96 EUR
|
( 112,577,806.25 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
3040 EUR
|
( 55,875,352.00 LBP )
|
● Cost/Day:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
●
Cost/Month:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
3040 EUR
|
( 55,875,352.00 LBP )
|
● Cost/Day:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
●
Cost/Month:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
3040 EUR
|
( 55,875,352.00 LBP )
|
● Cost/Day:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
●
Cost/Month:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
3040 EUR
|
( 55,875,352.00 LBP )
|
● Cost/Day:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
●
Cost/Month:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
3040 EUR
|
( 55,875,352.00 LBP )
|
● Cost/Day:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
●
Cost/Month:
|
6080 EUR
|
( 111,750,704.00 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
13202,15 SAR
|
( 53,209,076.76 LBP )
|
● Cost/Day:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
●
Cost/Month:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
13202,15 SAR
|
( 53,209,076.76 LBP )
|
● Cost/Day:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
●
Cost/Month:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
13202,15 SAR
|
( 53,209,076.76 LBP )
|
● Cost/Day:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
●
Cost/Month:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
13202,15 SAR
|
( 53,209,076.76 LBP )
|
● Cost/Day:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
●
Cost/Month:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
13202,15 SAR
|
( 53,209,076.76 LBP )
|
● Cost/Day:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
●
Cost/Month:
|
26404,3 SAR
|
( 106,418,153.52 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
2626 GBP
|
( 52,915,922.02 LBP )
|
● Cost/Day:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
●
Cost/Month:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
2626 GBP
|
( 52,915,922.02 LBP )
|
● Cost/Day:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
●
Cost/Month:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
2626 GBP
|
( 52,915,922.02 LBP )
|
● Cost/Day:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
●
Cost/Month:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
2626 GBP
|
( 52,915,922.02 LBP )
|
● Cost/Day:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
●
Cost/Month:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
2626 GBP
|
( 52,915,922.02 LBP )
|
● Cost/Day:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
●
Cost/Month:
|
5252 GBP
|
( 105,831,844.04 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
30097 NOK
|
( 52,075,936.19 LBP )
|
● Cost/Day:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
●
Cost/Month:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
30097 NOK
|
( 52,075,936.19 LBP )
|
● Cost/Day:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
●
Cost/Month:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
30097 NOK
|
( 52,075,936.19 LBP )
|
● Cost/Day:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
●
Cost/Month:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
30097 NOK
|
( 52,075,936.19 LBP )
|
● Cost/Day:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
●
Cost/Month:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
30097 NOK
|
( 52,075,936.19 LBP )
|
● Cost/Day:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
●
Cost/Month:
|
60194 NOK
|
( 104,151,872.38 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
28482,76 SEK
|
( 51,270,733.02 LBP )
|
● Cost/Day:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
●
Cost/Month:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
28482,76 SEK
|
( 51,270,733.02 LBP )
|
● Cost/Day:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
●
Cost/Month:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
28482,76 SEK
|
( 51,270,733.02 LBP )
|
● Cost/Day:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
●
Cost/Month:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
28482,76 SEK
|
( 51,270,733.02 LBP )
|
● Cost/Day:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
●
Cost/Month:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
28482,76 SEK
|
( 51,270,733.02 LBP )
|
● Cost/Day:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
●
Cost/Month:
|
56965,52 SEK
|
( 102,543,266.15 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
2662 EUR
|
( 48,927,693.10 LBP )
|
● Cost/Day:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
●
Cost/Month:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
2662 EUR
|
( 48,927,693.10 LBP )
|
● Cost/Day:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
●
Cost/Month:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
2662 EUR
|
( 48,927,693.10 LBP )
|
● Cost/Day:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
●
Cost/Month:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
2662 EUR
|
( 48,927,693.10 LBP )
|
● Cost/Day:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
●
Cost/Month:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
2662 EUR
|
( 48,927,693.10 LBP )
|
● Cost/Day:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
●
Cost/Month:
|
5324 EUR
|
( 97,855,386.20 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
12895,82 TRY
|
( 24,767,297.55 LBP )
|
● Cost/Day:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
●
Cost/Month:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
12895,82 TRY
|
( 24,767,297.55 LBP )
|
● Cost/Day:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
●
Cost/Month:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
12895,82 TRY
|
( 24,767,297.55 LBP )
|
● Cost/Day:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
●
Cost/Month:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
12895,82 TRY
|
( 24,767,297.55 LBP )
|
● Cost/Day:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
●
Cost/Month:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
12895,82 TRY
|
( 24,767,297.55 LBP )
|
● Cost/Day:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
●
Cost/Month:
|
25791,64 TRY
|
( 49,536,515.79 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
5033515 LBP
|
( 5,033,515.00 LBP )
|
● Cost/Day:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
●
Cost/Month:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
5033515 LBP
|
( 5,033,515.00 LBP )
|
● Cost/Day:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
●
Cost/Month:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
5033515 LBP
|
( 5,033,515.00 LBP )
|
● Cost/Day:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
●
Cost/Month:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
5033515 LBP
|
( 5,033,515.00 LBP )
|
● Cost/Day:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
●
Cost/Month:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
5033515 LBP
|
( 5,033,515.00 LBP )
|
● Cost/Day:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
●
Cost/Month:
|
10067030 LBP
|
( 10,067,030.00 LBP )
|
Prices are provided in Dollar ($)
You have to register to view this info
You have to register to view this info